A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä

The Prognostic Significance of Tertiary Lymphoid Structures in Head and Neck Cancers: A Systematic Review and Meta‐Analysis;




TekijätFreitas de Morais, Everton; da Costa, Bruno Cesar; Mäkitie, Antti; Coletta, Ricardo D.; Almangush, Alhadi

KustantajaWiley

Julkaisuvuosi2026

Lehti: Journal of Oral Pathology and Medicine

Artikkelin numerojop.70151

ISSN0904-2512

eISSN1600-0714

DOIhttps://doi.org/10.1111/jop.70151

Julkaisun avoimuus kirjaamishetkelläAvoimesti saatavilla

Julkaisukanavan avoimuus Osittain avoin julkaisukanava

Verkko-osoitehttps://doi.org/10.1111/jop.70151

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/526564372

Rinnakkaistallenteen lisenssiCC BY

Rinnakkaistallennetun julkaisun versioKustantajan versio


Tiivistelmä

Background: Head and neck squamous cell carcinoma (HNSCC), particularly oral squamous cell carcinoma (OSCC), is associated with poor survival despite therapeutic advances. Tertiary lymphoid structures (TLSs) are emerging components of the tumor microenvironment, but their prognostic significance in HNSCC remains unclear.

Objective: To systematically review and meta-analyze the prognostic impact of TLSs in HNSCC.

Methods: PubMed/MEDLINE, Scopus, ScienceDirect, and Embase were searched through August 2025. Eligible studies evaluated TLS presence, density, maturity, or spatial distribution in histologically confirmed HNSCC. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using fixed-effects models. Risk of bias and certainty of evidence were assessed using QUIPS and GRADE, respectively.

Results: Seventeen studies involving more than 2309 patients were included. TLS-positive tumors were significantly associated with improved overall and disease-free survival (DFS) (p < 0.001). Absence of TLSs was associated with worse overall survival (HR: 2.20, 95% CI: 1.74-2.78, I2 = 26%) and poorer DFS (HR: 2.21, 95% CI: 1.49-3.28, I2 = 0%). This adverse prognostic effect persisted in the OSCC subgroup (HR: 1.97, 95% CI: 1.42-2.73, I2 = 28%). Beyond quantitative presence, TLS maturation and spatial distribution influenced prognosis, with mature intratumoral TLSs associated with more favorable outcomes. Moreover, emerging evidence suggests that TLSs may also predict response to immunotherapy, particularly immune checkpoint blockade.

Conclusion: TLSs are strong prognostic biomarkers in HNSCC. Their presence, maturity, and spatial context significantly influence survival, supporting their role in prognostic stratification and future therapeutic strategies. TLS maturity emerges as a promising feature for standardized scoring systems and should be further explored in future studies.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
This research was funded by grants from Conselho Nacional de Desenvolvimento e Tecnológico (CNPq; grant 305781/2024-3 to R. D. Coletta). E. F. de Morais (2022/00994-5) and B. C. da Costa (2023/10632-6) are research fellows supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP.


Last updated on